HRMY
Harmony Biosciences Holdings
NASDAQ: HRMY · HEALTHCARE · BIOTECHNOLOGY
$31.26
+0.68% today
Updated 2026-04-30
Market cap
$1.80B
P/E ratio
11.46
P/S ratio
2.07x
EPS (TTM)
$2.71
Dividend yield
—
52W range
$26 – $41
Volume
1.0M
Harmony Biosciences Holdings (HRMY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
18.30%
Operating margin
15.80%
ROE
20.70%
ROA
11.50%
Debt/equity
0.20x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-39.90M | — | — | — |
| 2019 | $6.00M | $-151.98M | 73.69% | -2,433.76% | -2,535.06% |
| 2020 | $159.74M | $-36.94M | 82.64% | 10.63% | -23.13% |
| 2021 | $305.44M | $34.60M | 81.82% | 28.66% | 11.33% |
| 2022 | $437.86M | $181.47M | 80.93% | 27.45% | 41.44% |
| 2023 | $582.02M | $128.85M | 79.17% | 32.99% | 22.14% |
| 2024 | $714.73M | $145.49M | 78.06% | 26.70% | 20.36% |
| 2025 | $868.45M | $158.69M | 77.16% | 24.00% | 18.27% |